Article Information
History
- August 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Allan Musinguzi1,¶,
- Joan R. Kasidi1,¶,
- Jillian L. Kadota2,
- Fred Welishe1,
- Anne Nakitende1,
- Lydia Akello1,
- Jane Nakimuli1,
- Lynn T. Kunihira3,
- Bishop Opira1,
- Yeonsoo Baik4,
- Devika Patel5,6,
- Amanda Sammann5,6,
- Christopher A. Berger2,
- Hélène E. Aschmann7,
- Payam Nahid2,
- Robert Belknap8,
- Moses R. Kamya1,9,
- Margaret A. Handley10,
- Patrick PJ Phillips2,
- Noah Kiwanuka11,
- Achilles Katamba3,12,
- David W. Dowdy3,13,
- Adithya Cattamanchi2,3,14,
- Fred C. Semitala1,9,15,*,& and
- Anne R. Katahoire16,&
- 1Infectious Diseases Research Collaboration, Kampala, Uganda
- 2Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
- 3Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda
- 4Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 5Department of Surgery, University of California San Francisco, San Francisco, CA, USA
- 6The Better Lab, University of California, San Francisco, CA, USA
- 7Department of Epidemiology and Biostatistics and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
- 8Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, CO, USA
- 9Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
- 10Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
- 11Department of Epidemiology and Biostatistics, School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
- 12Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
- 13Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 14Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, CA, USA
- 15Makerere University Joint AIDS Program, Kampala, Uganda
- 16Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
- ↵*Corresponding author Email: semitala{at}gmail.com (FCS)
Posted August 22, 2024.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
